Menopur Lyophilisate For Solution For Injection 75-75iu Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Menopur: Lyophilisate for solution for injection (75-75IU)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MENOTROPINS (men oh TROE pins) is a fertility medicine. It is used to stimulate the ovaries. This may increase the chance of pregnancy.

In-Depth Information

Menopur 75unit Powder for Injection

NDC: 555667501
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Infertility

Sometimes used for but not FDA approved for the following conditions:
Hypogonadism, Oligospermia

Storage Information
Reconstituted product should be used immediately. Discard unused portion
Store unreconstituted product between 36 and 77 degrees F
Protect from light
Menopur 75unit Powder for Injection

Reported Side Effects for Menopur 75unit Powder for Injection

Blood Clot Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Irritated Blood Vessels Incidence:
<1.0%*
Severity: MODERATE
Onset: RAPID
Gynecomastia Incidence:
<30.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
<3.2%*
Severity: MILD
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Vomiting Incidence:
<4.2%*
Severity: MILD
Onset: EARLY
Brain Attack Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Hives Incidence:
<1.0%*
Severity: MILD
Onset: RAPID
Blood Clot In Lung Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Constipation Incidence:
<1.6%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<2.8%*
Severity: MILD
Onset: EARLY
Pelvic Pain Incidence:
0.4-3.9%*
Severity: MILD
Onset: DELAYED
Hot Flashes Incidence:
0.6-2.6%*
Severity: MODERATE
Onset: EARLY
Shortness Of Breath Incidence:
1.0-2.1%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
1.0-11.8%*
Severity: MILD
Onset: RAPID
Cough Incidence:
1.6-2.6%*
Severity: MILD
Onset: DELAYED
Breast Pain Incidence:
1.8-2.6%*
Severity: MILD
Onset: DELAYED
Ovarian Hyperstimulation Syndrome (OHSS) Incidence:
2.0-13.2%*
Severity: SEVERE
Onset: DELAYED
Flushing Incidence:
2.4%*
Severity: MILD
Onset: RAPID
Migraine Incidence:
2.4%*
Severity: MODERATE
Onset: EARLY
Feeling Sick Incidence:
2.6-2.8%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
2.6%*
Severity: MILD
Onset: EARLY
Vaginal Bleeding Incidence:
3.1-7.9%*
Severity: MODERATE
Onset: DELAYED
Upset Stomach Incidence:
4.0-12.0%*
Severity: MILD
Onset: EARLY
Enlarged Ovaries Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
5.0-17.6%*
Severity: MILD
Onset: EARLY
Headache Incidence:
5.2-34.1%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Menopur

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5